Webinar

2024-0222 GVIRF Webinar: New TB Vaccines for Adults & Adolescents: Progress, Prospects and Perspectives; February 22, 2024 - FINAL AGENDA

Final agenda as of January 26, 2024.

Languages

  • English

Publication year

2024

Type

Webinar

Categories

  • Global initiatives

Topic references

GVIRF-webinar

TitleAuthorYearTypeLanguage
2021-10-14 mRNA Vaccine Technologies for Global Health - AGENDAGVIRF Secretariat2021PresentationEnglish
2021-10-14 mRNA Vaccine Technologies for Global Health - PRESENTATIONSGVIRF Secretariat2021PresentationEnglish
2021-10-14 mRNA Vaccine Technologies for Global Health - VIDEOGVIRF Secretariat2022WebinarEnglish
2022-03-03 Malaria Vaccine R&D and Immunization Lessons Learned and Considerations for Global Health Impact - VIDEOGVIRF Secretariat2022WebinarEnglish
2022-03-03 Malaria Vaccine R&D and Immunization: Lessons Learned and Considerations for Global Health Impact - AGENDAGVIRF Secretariat2022PresentationEnglish
2022-06-23 AMR: Las vacunas como herramientas para prevenir la RAM - VIDEOGVIRF Secretariat2022WebinarSpanish
2022-06-23 AMR: Les vaccins comme outils de prévention de la RAM - VIDEOGVIRF Secretariat2022WebinarFrench
2022-06-23 AMR: Vaccines as Tools to Prevent Antimicrobial Resistance - VIDEOGVIRF Secretariat2022WebinarEnglish
2022-06-23 AMR: Vaccines as Tools to Prevent Antimicrobial Resistance: Advances, challenges, and future development - AGENDAGVIRF Secretariat2022PresentationEnglish
2022-06-23 Vaccines as Tools to Prevent Antimicrobial Resistance: Advances, challenges, and future development - WEBINAR ANNOUNCEMENTGVIRF Secretariat2022PresentationEnglish
2022-10-12 Correlates of Protection - VIDEOGVIRF Secretariat2022WebinarEnglish
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Final AGENDAGVIRF Secretariat2023WebinarEnglish
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Session I Global Demand for Vaccine AdjuvantsGVIRF Secretariat2023PresentationEnglish
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Session II Selection of Adjuvant and Formulation for Vaccine R&D: rational or empirical?GVIRF Secretariat2023PresentationEnglish
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Session III Access to AdjuvantsGVIRF Secretariat2023PresentationEnglish
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - VIDEOGVIRF Secretariat2023WebinarEnglish
2024-0222 GVIRF Webinar: New TB Vaccines for Adults & Adolescents: Progress, Prospects and Perspectives; February 22, 2024 - FINAL AGENDAGVIRF Secretariat2024WebinarEnglish
2024-0222 GVIRF Webinar: New TB Vaccines for Adults and Adolescents - VIDEOGVIRF Secretariat2024WebinarEnglish
2024-0222 GVIRF Webinar: New TB Vaccines for Adults and Adolescents, Progress, Prospects, and Perspectives, February 22, 2024 - ANNOUNCEMENTGVIRF Secretariat2024WebinarEnglish
2024-0222 GVIRF Webinar: New Tuberculosis Vaccines for Adults and Adolescents: Progress, Prospects, and Perspectives - PRESENTATIONSGVIRF Secretariat, Richard White, Nebiat Gebreselassie, Mark Hatherill, Ann Ginsberg, Nicole Frahm, Munyaradzi Musvosvi, David Lewinsohn, Shelly Malhotra, Rupali Limaye, Birgitte Giersing2024PresentationEnglish
2024-0222 GVIRF Webinar: Nouveaux vaccins antituberculeux pour adultes et adolescents - VIDEOGVIRF Secretariat2024WebinarFrench
2024-0222 GVIRF Webinar: Nuevas vacunas contra la tuberculosis para adultos y adolescentes - VIDEOGVIRF Secretariat2024WebinarSpanish

Added by: Angela Hwang

Added on: 2024-01-26 05:07:14

Hits: 855

Uploaded file

GVIRF Webinar TB February 2024 Agenda v3.pdf

Click to Download